These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35236179)

  • 41. Control of renal uric acid excretion and gout.
    Taniguchi A; Kamatani N
    Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tea and its components reduce the production of uric acid by inhibiting xanthine oxidase.
    Wu D; Chen R; Zhang W; Lai X; Sun L; Li Q; Zhang Z; Cao J; Wen S; Lai Z; Li Z; Cao F; Sun S
    Food Nutr Res; 2022; 66():. PubMed ID: 35844955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
    Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
    Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
    Kuriyama S
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):1-5. PubMed ID: 31754883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong province].
    Yu JW; Yang TG; Diao WX; Cai XQ; Li T; Zhong H; Hu DL; Chen CQ; Chen ZX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Aug; 31(8):860-2. PubMed ID: 21162982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-Fructose Diet-Induced Hyperuricemia Accompanying Metabolic Syndrome-Mechanisms and Dietary Therapy Proposals.
    Lubawy M; Formanowicz D
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
    Takahashi T; Beppu T; Hidaka Y; Hosoya T
    Clin Exp Hypertens; 2021 Nov; 43(8):730-741. PubMed ID: 34425059
    [No Abstract]   [Full Text] [Related]  

  • 48. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice.
    Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q
    Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present).
    Shi X; Zhao T; da Silva-Júnior EF; Zhang J; Xu S; Gao S; Liu X; Zhan P
    Expert Opin Ther Pat; 2022 Dec; 32(12):1175-1184. PubMed ID: 36625031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.
    Wu XH; Wang CZ; Wang SQ; Mi C; He Y; Zhang J; Zhang YW; Anderson S; Yuan CS
    J Ethnopharmacol; 2015 Mar; 162():362-8. PubMed ID: 25617746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease　- Japanese Guideline on the Management of Asymptomatic Hyperuricemia.
    Hisatome I; Li P; Miake J; Taufiq F; Mahati E; Maharani N; Utami SB; Kuwabara M; Bahrudin U; Ninomiya H
    Circ J; 2021 Jan; 85(2):130-138. PubMed ID: 33342914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances on uric acid transporters.
    Xu L; Shi Y; Zhuang S; Liu N
    Oncotarget; 2017 Nov; 8(59):100852-100862. PubMed ID: 29246027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.
    Nishizawa H; Maeda N; Shimomura I
    Hypertens Res; 2022 Apr; 45(4):635-640. PubMed ID: 35046512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Xanthine oxidase inhibitory activity and antihyperuricemic effect of Moringa oleifera Lam. leaf hydrolysate rich in phenolics and peptides.
    Tian Y; Lin L; Zhao M; Peng A; Zhao K
    J Ethnopharmacol; 2021 Apr; 270():113808. PubMed ID: 33450289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies.
    Wang J; Chen Y; Zhong H; Chen F; Regenstein J; Hu X; Cai L; Feng F
    Crit Rev Food Sci Nutr; 2022; 62(14):3979-3989. PubMed ID: 33480266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taurine decreased uric acid levels in hyperuricemic rats and alleviated kidney injury.
    Feng Y; Sun F; Gao Y; Yang J; Wu G; Lin S; Hu J
    Biochem Biophys Res Commun; 2017 Jul; 489(3):312-318. PubMed ID: 28552532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonpharmacological Management of Gout and Hyperuricemia: Hints for Better Lifestyle.
    Kakutani-Hatayama M; Kadoya M; Okazaki H; Kurajoh M; Shoji T; Koyama H; Tsutsumi Z; Moriwaki Y; Namba M; Yamamoto T
    Am J Lifestyle Med; 2017; 11(4):321-329. PubMed ID: 30202351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.